Mark Zuckerberg-Backed AI Startup Takes Over Parkinson’s Treatment From the Maker of Ozempic

Gizmodo
Read full post
A startup supported by Mark Zuckerberg has acquired the company that developed Ozempic to advance Parkinson's disease treatment. This move aims to innovate therapies for Parkinson's by leveraging AI technologies.

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources
Healthcare5 min read

​Digital Finance Needs A New Kind Of Identity For AI-Driven Economies

Forbes

How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules

Open AI News